Safety and Efficacy of Corneal Crosslinking Using the PXL-Platinum 330 for Eyes With Corneal Ectatic Conditions

Stopped early · Phase 2

Conditions studied: Keratoconus, Cornea Ectasia

In brief

To evaluate the safety and effectiveness of the PXL Platinum 330 device for performing Corneal Crosslinking in patients with corneal thinning conditions.

Key facts

Study ID
NCT04240457
Run by
Arbor Center for Eye Care
People needed
11
Starts
2020-07-08
Expected to finish
2023-02-18
Last updated by the study team
2024-12-12

Who can join

Age: 12 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.